odapipam has been researched along with xanomeline in 1 studies
| Studies (odapipam) | Trials (odapipam) | Recent Studies (post-2010) (odapipam) | Studies (xanomeline) | Trials (xanomeline) | Recent Studies (post-2010) (xanomeline) |
|---|---|---|---|---|---|
| 19 | 4 | 3 | 124 | 16 | 41 |
| Protein | Taxonomy | odapipam (IC50) | xanomeline (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.1644 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0251 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.3967 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, JV; Hansen, KT | 1 |
1 other study(ies) available for odapipam and xanomeline
| Article | Year |
|---|---|
Normal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline.
Topics: Animals; Benzazepines; Benzofurans; Chromatography, High Pressure Liquid; Dopamine Antagonists; Male; Mass Spectrometry; Microsomes, Liver; Muscarinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiadiazoles | 1997 |